Chinese Public Companies
Aluminum Corp. of China
Asia Payment Systems
China Automotive Systems
China Eastern Airlines
China Cable & Comm.
China National Offshore Oil
China Energy Savings Tec
China Techfaith Wireless
China Medical Technology
China Yuchai International
Jilin Chemical Industrial J
51 Job, Inc.
China Finance Online
China Life Insurance
Ninetowns Digital World
Nam Tai Electronics
Qiao Xing Telephone
Yanzhou Coal Mining
China Southern Airlines
China Medical Technologies (Ticker: CMED)
Company Profile and Private Investigations
China Medical Technologies is a company in the health care industry.
China Medical Technologies' HIFU therapy system treats solid tumor cancers
and benign tumors using linear ultrasound waves to raise the temperature of
the targeted tumor tissue. The system is used primarily to treat liver,
lung, breast, prostate, and kidney cancers, along with tumors in arms and
legs and superficial tissues. Its ECLIA system is a luminescence immunoassay
diagnostic system used to detect thyroid disorders, diabetes, reproductive
disorders, SARS, and tumor markers. China Medical Technologies offers 27
reagent kits for use with the ECLIA system. Founder and CEO Xiaodong Wu owns
about 55% of the company, which operates through subsidiary YDME Beijing.
China Medical Technologies' website describes the company as follows:
Beijing Yuande Bio-Medical Engineering Co.,Ltd. is a high-tech enterprise
engaged in the R&D and production of large-scale medical equipments,
instruments and reagents. At present, major shareholders of the company
include Chengxuan International Company, Golden Meditech Co.,Ltd. and GE
Healthcare Group. The company was founded in 1999 and located at Beijing
Economical & Technological Development Zone. We passed the International
Quality System Certification of ISO9001 in 2001.
Cooperated with researchers from Peking University, we have developed High
Intensity Focused Ultrasound (HIFU) tumor therapy system through years of
efforts with considerable investments. The equipment was granted the
register and manufacture license by State Drug Administration in 1999.
Moreover, this project has been listed as a State High-Tech
Industrialization Advanced Project and approved by Science Research Fund of
the Ministry of Public Health. The success in clinical application of High
Intensity Focused Ultrasound tumor therapy system has realized the dream of
non-invasive treatment of tumor. The product has got many patents both in
China and abroad. Having been evaluated and demonstrated by senior experts
for many times, the clinical application of this technology is considered to
have reached world leading level.
Through efforts on the research of chemiluminescence analysis, we are the
first China-based company to grasp the core technology thereof, and the
first to have a platform to develop and manufacture both equipment and
reagent. We launched of our Enhanced Chemiluminescence Immunoassay (ECLIA)
analysis system and reagents in 2004.
We have a modern factory to produce High Intensity Focused Ultrasound tumor
therapy system, ECLIA system and reagents and to carry out the R&D of new
products. Our company is managed by experienced professional team and
talented scientists. We have established nation-wide sale and customer
service network. Sustained technical innovation, strict quality control and
comprehensive after-sales service constitute our core competence, and create
a solid foundation for our healthy growth.
The name and description sound good. But how is the company?
Our Private Investigations:
On August 22, 2005, we tried several times to dial the phone numbers of
China Medical Technologies, or Beijing Yuande Bio-Medical Engineering Co.,Ltd.
The phone number we tried was (86 10) 67871166, which was listed on the
company's website at http://www.yuande.com/cus.html . Unfortunately, no one
answered the phone call.
Although its name sounds big and powerful, our associate who is currently
in medical equipment supplies industry has never heard of China Medical
Technologies, and the company currently only has two products. How are
these two products? For details, please see our
China Investment Report
contact us for
advertisement information and other matters.